Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Trump 2.0 presents opportunities, threats

A clear understanding of threats and opportunities will be essential as the biopharma industry steps into the second Trump administration

November 23, 2024 3:24 AM UTC

Nothing has changed in Washington, but two months ahead of inauguration day, it already feels as if everything is different. Biopharma leaders believe there is an urgent need to seize the opportunities and head off threats posed by the incoming administration.

A consensus has emerged among pharmaceutical and biotech CEOs who are trying to plot a course through the transition and into the new Congress and administration. They are looking for areas of common ground with President-elect Donald Trump and his nominees for critical positions, hoping to steer clear of conflict, and sketching out red lines that would lead them to go on the offensive. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article